A method for breeding Tibetan sheep with high immunity using molecular markers and its application
By discovering and utilizing the T or C mutation site at the 12,602,479th base in the Tibetan sheep genome, we designed primer pairs for PCR amplification and genotype analysis, which solved the difficulty in screening Tibetan sheep with high disease resistance in the existing technology. Sheep problem, achieving efficient screening and breeding support for Tibetan sheep immunity.
Patent Information
- Application Number
- CN202410843126.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-27
- Publication Date
- 2025-01-21
- Estimated Expiration
- 2044-06-27
AI Technical Summary
In the prior art, there are few molecular markers related to the immunity of Tibetan sheep, and it is difficult to efficiently screen Tibetan sheep with high disease resistance, which affects the development of the Tibetan sheep industry.
Through the T or C mutation site found at base 12602479 on chromosome 12 of the Oar_v4.0 version of the sheep reference genome, we designed primer pairs for PCR amplification, analyzed the correlation between different genotypes and immunoglobulin content, and screened Tibetan sheep with high immunoglobulin content were found.
Efficient screening of Tibetan sheep immunity was achieved, and Tibetan sheep individuals with high immunity and disease resistance were obtained, which provided an important basis for Tibetan sheep breeding.
Smart Images

Figure CN118703637B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of molecular biological detection, and in particular relates to a method for using molecular markers to assist in breeding Tibetan sheep with high immunity and its application. Background Art
[0002] Tibetan sheep are the main livestock living in the Qinghai-Tibet Plateau and an important part of grassland animal husbandry in the high-altitude pastoral areas of the Qinghai-Tibet Plateau. The Tibetan sheep population is large and widely distributed, and has unique biological characteristics, providing necessary resources for the production and life of the Tibetan people. Due to the harsh environment in the Qinghai-Tibet Plateau, sheep with high immunity and high disease resistance are needed to adapt to the environment of the region. However, there are currently defects in the breeding of sheep, such as insufficient breeding, small group size, and difficulty in meeting market demand. These defects affect the development of the Tibetan sheep industry.
[0003] Immune indicators can be used as an important reference to evaluate the disease resistance and health status of Tibetan sheep. By detecting changes in immune indicators, immune problems of Tibetan sheep can be discovered in time, and corresponding measures can be taken to improve their disease resistance, prevent and treat diseases. It can be seen that studying the immunity of Tibetan sheep can reflect the disease resistance of Tibetan sheep and provide an important basis for the auxiliary breeding of Tibetan sheep.
[0004] With the rapid development of molecular marker technology, in Tibetan sheep breeding, the mutation sites in genes are searched at the gene level, and the relationship between genes and traits is discovered through association analysis between genes and traits, so that early selection can be carried out to improve the efficiency and accuracy of seed selection, which has broad application value. Therefore, molecular markers provide a basis for people to study the genetic mechanism of immunity of Tibetan sheep at the molecular level, and screening corresponding molecular markers for more efficient use in Tibetan sheep breeding is an important issue in this field. There are not many molecular markers related to Tibetan sheep immunity in the prior art for molecular marker-assisted selection related to immunity. It is particularly important to provide a molecular marker related to the immune traits of Tibetan sheep, so as to be used in molecular marker-assisted breeding of Tibetan sheep to screen Tibetan sheep with high disease resistance. Summary of the invention
[0005] The purpose of the present invention is to provide a method for breeding Tibetan sheep with high immunity by using molecular markers and its application.
[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0007] The invention provides a molecular marker for improving the immunity of Tibetan sheep. The molecular marker is located at the 12602479th base on chromosome 12 of the sheep reference genome Oar_v4.0 version, and the mutant base is T or C.
[0008] Preferably, the genotype of the Tibetan sheep with the mutant base T is TT or TC;
[0009] The genotype of Tibetan sheep with the mutant base C is CC;
[0010] The immunoglobulin content in Tibetan sheep with CC genotype was significantly higher than that in Tibetan sheep with TC or TT genotype.
[0011] There was no significant difference in the immunoglobulin content between Tibetan sheep with genotype TT and Tibetan sheep with genotype TG.
[0012] The immunoglobulin is one or more of immunoglobulin A, immunoglobulin G and immunoglobulin M.
[0013] The present invention also provides the application of the molecular marker in in vitro detection of immune traits of Tibetan sheep for non-diagnostic purposes.
[0014] The invention also provides the application of the molecular marker in assisting the breeding of Tibetan sheep with high immunity.
[0015] The present invention also provides a primer pair for amplifying the molecular marker, and the primer pair is shown as SEQ ID NO.1-2.
[0016] The present invention also provides the application of the primer pair in in vitro detection of immune traits of Tibetan sheep for non-diagnostic purposes.
[0017] The invention also provides application of the primer pair in assisting breeding of Tibetan sheep with high immunity.
[0018] The present invention also provides a method for breeding Tibetan sheep with high immunity by using molecular markers, comprising the following steps:
[0019] (1) Extracting Tibetan sheep genomic DNA;
[0020] (2) using the genomic DNA obtained in step (1) as a template and using the primer pair to amplify to obtain a PCR amplification product;
[0021] (3) performing genotyping analysis on the PCR amplification products to obtain Tibetan sheep with different genotypes, associating the genotypes of the Tibetan sheep with immunoglobulins, screening Tibetan sheep with high immunoglobulin content, and obtaining Tibetan sheep with high immunity;
[0022] The genotype of Tibetan sheep with molecular marker locus T is TT or TC;
[0023] The genotype of Tibetan sheep with molecular marker locus C is CC;
[0024] The amplification system in step (2) is: 21-23 μL of gold mix (green), 0.8-1.2 μL of upstream and downstream primers, and 0.8-1.2 μL of template;
[0025] The amplification program in step (2) is: 98°C for 2 min; 98°C for 10 s, 57.5°C for 10 s, 72°C for 10 s, for a total of 40 cycles; and extension at 72°C for 2 min.
[0026] The invention also provides application of the method in screening Tibetan sheep with high immunity.
[0027] The present invention also provides a kit for assisting in breeding Tibetan sheep with high immunity, comprising the molecular marker or the primer pair.
[0028] The present invention provides a method for assisting the breeding of Tibetan sheep with high immunity using molecular markers and its application. The present invention relates to a molecular marker for improving the immunity of Tibetan sheep, wherein the molecular marker is located at the 12602479th base on chromosome 12 of the sheep reference genome Oar_v4.0 version, and the mutant base is T or C. When the 12602479th base is T, the genotype is TT or TC; when the 12602479th base is C, the genotype is CC; through the association analysis of different genotypes with the content of immunoglobulin A, immunoglobulin G, and immunoglobulin M, it is found that the content of immunoglobulin A, immunoglobulin G, and immunoglobulin M in Tibetan sheep individuals with genotype CC is significantly higher than that in Tibetan sheep individuals with genotype TC or TT (p<0.05); the content of immunoglobulin A, immunoglobulin G, and immunoglobulin M in Tibetan sheep individuals with genotype TC and Tibetan sheep individuals with genotype TT is not significantly different. The present invention also provides a primer pair that can amplify the gene fragment at the 12602479th base. The primer pair and the method for molecular marker-assisted breeding of Tibetan sheep with high immunity can detect the base at the 12602479th nucleotide site on the chromosome 12 of Tibetan sheep, and can obtain the content of immunoglobulin A, immunoglobulin G and immunoglobulin M in Tibetan sheep individuals, providing a new molecular marker resource for marker-assisted selection of Tibetan sheep immune traits for non-diagnostic purposes, and providing a basis for breeding Tibetan sheep with high immunity and high disease resistance. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 is the PCR amplification product; M represents Marker; 1, 2, and 3 represent three groups of repetitions.
[0030] Figure 2 The peak diagram and sequence are obtained after the PCR product is purified and sequenced. DETAILED DESCRIPTION
[0031] The invention provides a molecular marker for improving the immunity of Tibetan sheep. The molecular marker is located at the 12602479th base on chromosome 12 of the sheep reference genome Oar_v4.0 version, and the mutant base is T or C.
[0032] In the present invention, the genotype of the Tibetan sheep with the mutant base T is TT or TC;
[0033] The genotype of Tibetan sheep with the mutant base C is CC;
[0034] The immunoglobulin content in Tibetan sheep with CC genotype was significantly higher than that in Tibetan sheep with TC or TT genotype.
[0035] There was no significant difference in the immunoglobulin content between Tibetan sheep with genotype TT and Tibetan sheep with genotype TG.
[0036] The immunoglobulin is one or more of immunoglobulin A, immunoglobulin G and immunoglobulin M.
[0037] The present invention also provides the application of the molecular marker in in vitro detection of immune traits of Tibetan sheep for non-diagnostic purposes.
[0038] The invention also provides the application of the molecular marker in assisting the breeding of Tibetan sheep with high immunity.
[0039] The present invention also provides a primer pair for amplifying the molecular marker, and the primer pair is shown as SEQ ID NO.1-2.
[0040] SEQ ID NO.1 is an upstream primer, and the specific sequence is 5'-GTATAAACTTCAGTGACTGGC-3'; SEQ ID NO.2 is a downstream primer, and the specific sequence is 5'-TCAGTGATGGGTAAAATCAGC-3'. The primer was synthesized by Beijing Qingke Biotechnology Co., Ltd. The length of the gene fragment amplified by the primer is 583 bp.
[0041] The present invention also provides the application of the primer pair in in vitro detection of immune traits of Tibetan sheep for non-diagnostic purposes.
[0042] The invention also provides application of the primer pair in assisting breeding of Tibetan sheep with high immunity.
[0043] The present invention also provides a method for breeding highly immune Tibetan sheep using molecular markers, comprising the following steps:
[0044] (1) Extracting Tibetan sheep genomic DNA;
[0045] (2) using the genomic DNA obtained in step (1) as a template and using the primer pair to amplify to obtain a PCR amplification product;
[0046] (3) performing genotyping analysis on the PCR amplification products to obtain Tibetan sheep with different genotypes, associating the genotypes of the Tibetan sheep with immunoglobulins, screening Tibetan sheep with high immunoglobulin content, and obtaining Tibetan sheep with high immunity;
[0047] The genotype of Tibetan sheep with molecular marker locus T is TT or TC;
[0048] The genotype of Tibetan sheep with molecular marker locus C is CC;
[0049] The amplification system in step (2) is: 21-23 μL of gold mix (green), preferably 22 μL, 0.8-1.2 μL of upstream and downstream primers, preferably 1.0 μL, and 0.8-1.2 μL of template, preferably 1.0 μL;
[0050] The amplification program in step (2) is: 98°C for 2 min; 98°C for 10 s, 57.5°C for 10 s, 72°C for 10 s, for a total of 40 cycles; and extension at 72°C for 2 min.
[0051] The invention also provides application of the method in screening Tibetan sheep with high immunity.
[0052] The present invention also provides a kit for assisting in breeding Tibetan sheep with high immunity, comprising the molecular marker or the primer pair.
[0053] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0054] Example
[0055] 1. Sample collection
[0056] The samples came from Tibetan sheep populations under natural grazing conditions, including 40 samples from Gannan Tibetan Autonomous Prefecture, Gansu Province, 50 samples from Yushu Tibetan Autonomous Prefecture, Qinghai Province, and 40 samples from Shigatse City, Tibet Autonomous Region. 5 mL of blood samples were collected from 130 fasting Tibetan sheep and placed in a clean pro-coagulant vacuum blood collection tube, left to stand for 30 minutes, and then centrifuged at 3500r / min for 15 minutes. The supernatant was aspirated into a clean PE tube, which was sealed and stored in a -20℃ low-temperature refrigerator. Another 5 mL of blood sample was collected in a blood collection tube with EDTA-K2 anticoagulant added. After the blood sample was collected, it was quickly mixed and temporarily stored in a sampling box containing ice packs. After being transported back to the laboratory, it was frozen in a -20℃ refrigerator for extraction of genomic DNA.
[0057] 2 Main reagents and instruments
[0058] Blood collection tubes with EDTA-K2 anticoagulant were purchased from Jiangsu Yuli Medical Instrument Co., Ltd.; the blood genomic DNA extraction kit was purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd.; NanoDrop2000 spectrophotometer was purchased from ThermoFisher Scientific, USA; DL2000 Marker, agarose, and nucleic acid dyes were purchased from Beijing Solebow Technology Co., Ltd.; Gold Medal Mix (green) was purchased from Beijing Qingke Biotechnology Co., Ltd.; electrophoresis instrument was purchased from Beijing Liuyi Instrument Factory; PCR instrument was purchased from BioRad. Immunoglobulin A (IgA) (E027-1-1), immunoglobulin G (IgG) (E026-1-1), and immunoglobulin M (IgM) (E025-1-1) detection kits were purchased from Nanjing Jiancheng Bioengineering Institute.
[0059] 3 Methods
[0060] 3.1 IgA, IgG, and IgM testing
[0061] According to the IgA, IgG, and IgM detection kits of Nanjing Jiancheng Bioengineering Institute, the determination was performed using a spectrophotometer. First, a standard curve was established using a standard product; secondly, distilled water, a standard solution, and 7 μL of the sample to be tested were added to the blank tube, standard tube, and measurement tube, respectively, and R1 solution was added to 900 μL, incubated at 37°C for 5 minutes, and the reading at a wavelength of 340 nm was recorded as A1; then 180 μL of R2 solution was added to each tube, incubated at 37°C for 5 minutes, and the reading at a wavelength of 340 nm was recorded as A2; finally, △A was calculated as A2-A1, and △A was substituted into the standard curve equation to calculate the sample IgA, IgG, and IgM concentrations.
[0062] 3.2 Extraction of genomic DNA from blood
[0063] The blood genome extraction kit of Tiangen Biochemical Technology (Beijing) Co., Ltd. was used to extract genomic DNA from the blood samples. The extracted DNA was placed under an ultraviolet spectrophotometer to detect the concentration and purity. The concentration was greater than 20 ng / μL and OD260 / OD280 was between 1.7 and 1.9, which met the experimental requirements. It was stored at -20°C for future use.
[0064] 3.3 Primer design
[0065] Referring to the gene sequence of chromosome 12 of the international sheep genome Oar_v4.0 version (GenBank accession number: NC_019469.2), a pair of specific primers were designed using primerpremier5.0 software, including the g12602479T>C SNP site. The nucleotides of the primer pair are shown in SEQ ID NO.1-2. SEQ ID NO.1 is the upstream primer, and its sequence is: 5'-GTATAAACTTCAGTGACTGGC-3'; SEQ ID NO.2 is the downstream primer, and its sequence is: 5'-TCAGTGATGGGTAAAATCAGC-3'.
[0066] The length of the amplified fragment was 348 bp, and the primers were synthesized by Beijing Qingke Biotechnology Co., Ltd.
[0067] 3.4 PCR amplification and sequencing
[0068] PCR amplification system 25 μL: Gold Mix (green) 22 μL, upstream and downstream primers 1 μL each, template DNA 1 μL.
[0069] PCR amplification program: 98°C for 2 min; 98°C for 10 s, 57.5°C for 10 s, 72°C for 10 s, for a total of 40 cycles; extension at 72°C for 2 min.
[0070] The PCR product was detected by 1.5% agarose gel electrophoresis. After the PCR product was qualified by agarose gel electrophoresis, it was sequenced by direct sequencing, and the sequencing was completed by Beijing Qingke Biotechnology Co., Ltd. The amplified nucleotide sequence is shown in SEQ ID NO.3, and the SNP marker is located at position 342 of the nucleotide sequence described in SEQ ID NO.3.
[0071] The biological analysis software MEGA6.0 was used to compare the sequencing results of PCR products, analyze the sequencing peak graph, and complete the typing.
[0072] SEQ ID NO.3:.
[0073] 4 Statistical analysis
[0074] According to the genotyping results, the number of individuals with different genotypes at each site was counted. Popgen32 software was used to calculate the g12602479T>C gene frequency, genotype frequency, effective allele number (Ne), site heterozygosity (He), and Hardy-Weinberg equilibrium test, and PIC (polymorphism information content, referred to as PIC) calculation software was used to calculate the polymorphic information content. The general linear model in IBM SPSS Statistics 22 software was used to analyze the association between different genotypes of Tibetan sheep and IgA, IgG, and IgM, and the results were expressed as "mean ± standard error".
[0075] 5 Results
[0076] 5.1 PCR amplification and sequencing results
[0077] The amplified product of the g12602479T>CSNP locus of the Tibetan sheep chromosome 12 was detected by 1.5% agarose gel (see Figure 1 ), the bands were clear without any other bands, the specificity was good, and the PCR product fragment size was 583bp, which was in line with the expected size, so the next step of the experiment could be carried out.
[0078] The peak diagram and sequence obtained after the PCR product was purified and sequenced are shown in Figure 2 .Depend on Figure 2 It can be seen that the TC mutation occurred at the g12602479T>CSNP site, and there are three genotypes: TT, TC, and CC.
[0079] 5.2 Statistical analysis results
[0080] The genotype and allele frequencies of the g12602479T>CSNP locus on chromosome 12 of Tibetan sheep were analyzed from the perspective of population genetics. As shown in Table 1, at the g12602479T>CSNP locus, the TT genotype frequency was the highest, which was the dominant genotype, and the T allele frequency was 94.6%, which was the dominant allele. The χ2 fitness test showed that the SNP locus deviated significantly from the Hardy-Weinberg equilibrium state (P<0.05) (Table 1). The expected heterozygosity of this locus was 1.113, the PIC was 0.097, and the PIC was <0.25, which was a low degree of polymorphism.
[0081] Table 1 Polymorphism of g12602479T>CSNP locus on chromosome 12 of Tibetan sheep
[0082]
[0083] 5.3 Association analysis between different genotypes and IgA, IgG, and IgM
[0084] The general linear model in IBM SPSS Statistics 22 software was used to analyze the association between different genotypes of Tibetan sheep and the content of immunoglobulins IgA, IgG, and IgM. The results showed that the immunoglobulins IgA, IgG, and IgM of Tibetan sheep individuals with CC genotype were significantly higher than those of individuals with TC and TT genotypes (p<0.05), and there was no significant difference in the immunoglobulins IgA, IgG, and IgM of Tibetan sheep individuals with TT and TC genotypes. This indicates that the base of the g12602479T>CSNP site on chromosome 12 of Tibetan sheep is significantly correlated with IgA, IgG, and IgM of Tibetan sheep, and is a SNP marker related to IgA, IgG, and IgM of Tibetan sheep. The results are shown in Table 2.
[0085] Table 2 Relationship between different genotypes and immunoglobulins A, G and M
[0086]
[0087] Note: Different lowercase letters between data in the same row indicate significant differences (P<0.05).
[0088] The present invention provides a method for assisting the breeding of Tibetan sheep with high immunity using molecular markers and its application. The present invention relates to a molecular marker for improving the immunity of Tibetan sheep, wherein the molecular marker is located at the 12602479th base on chromosome 12 of the sheep reference genome Oar_v4.0 version, and the mutant base is T or C. When the 12602479th base is T, the genotype is TT or TC; when the 12602479th base is C, the genotype is CC; through the association analysis of different genotypes with the content of immunoglobulin A, immunoglobulin G, and immunoglobulin M, it is found that the content of immunoglobulin A, immunoglobulin G, and immunoglobulin M in Tibetan sheep individuals with genotype CC is significantly higher than that in Tibetan sheep individuals with genotype TC or TT (p<0.05); the content of immunoglobulin A, immunoglobulin G, and immunoglobulin M in Tibetan sheep individuals with genotype TC and Tibetan sheep individuals with genotype TT is not significantly different. The present invention also provides a primer pair that can amplify the gene fragment at the 12602479th base. The primer pair and the method for molecular marker-assisted breeding of Tibetan sheep with high immunity can detect the base at the 12602479th nucleotide site on the chromosome 12 of Tibetan sheep, and can obtain the content of immunoglobulin A, immunoglobulin G and immunoglobulin M in Tibetan sheep individuals, providing a new molecular marker resource for marker-assisted selection of Tibetan sheep immune traits for non-diagnostic purposes, and providing a basis for breeding Tibetan sheep with high immunity and high disease resistance.
[0089] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. Use of a reagent for detecting molecular markers related to immune traits of Tibetan sheep in the preparation of a product for detecting immunity of Tibetan sheep, characterized in that: The molecular marker is located at the 12602479th base on chromosome 12 of the sheep reference genome Oar_v4.0 version, and the mutant base is T or C; According to the molecular marker alleles, Tibetan sheep have three genotypes: TT, TC or CC; The immunoglobulin content in Tibetan sheep with CC genotype was significantly higher than that in Tibetan sheep with TC or TT genotype. There was no significant difference in the immunoglobulin content between Tibetan sheep with genotype TT and that with genotype TC.
2. Application of a reagent for detecting molecular markers of Tibetan sheep immunity in the preparation of products for assisting breeding of Tibetan sheep with high immunity, characterized in that: The molecular marker is located at the 12602479th base on chromosome 12 of the sheep reference genome Oar_v4.0 version, and the mutant base is T or C; According to the molecular marker alleles, Tibetan sheep have three genotypes: TT, TC or CC; The immunoglobulin content in Tibetan sheep with CC genotype was significantly higher than that in Tibetan sheep with TC or TT genotype. There was no significant difference in the immunoglobulin content between Tibetan sheep with genotype TT and that with genotype TC.
3. The use according to claim 1 or 2, characterized in that: The reagent is a primer pair; The primer pair is shown in SEQ ID NO.1~2.
4. The use according to claim 1 or 2, characterized in that: The immunoglobulin is one or more of immunoglobulin A, immunoglobulin G and immunoglobulin M.